Guardant Health Inc

Financials

Overview Finanzbericht Statistics Dividends

Cash from operating activities 103.93 M209.02 M309.46 M324.98 M239.86 M184.76 M 184.76 M Cash from investing activities 617.09 M63.16 M149.82 M840.25 M261.31 M627.2 M 627.2 M Cash from financing activities 1.41 B66.82 M189.09 M477.38 M996 K671.13 M 671.13 M Free cash flow 49.87 M133.98 M232 M304.49 M204.77 M136.45 M 136.45 M

Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.

GH

Financials

Guardant Health Inc

Nachrichten

ARK-ETFs: Cathie Wood kauft Kratos-Aktien und stößt Teradyne ab

Allspring Smid Cap Growth Fund Q4 2025 Top Contributors And Detractors

Stifel hebt Kursziel für Guardant Health nach Prognose an

Stifel raises Guardant Health stock price target on guidance outlook

Canaccord Genuity raises Guardant Health stock price target on revenue growth

Stock Market Today: Nasdaq Gains As Trump Addresses Tariff Ruling; Alphabet Heads Higher (Live Coverage)

Stock Market Today: Nasdaq Leads Charge On Tariff News; Amazon Jumps As Data Play Surges (Live Coverage)

Dow Jones Futures: Stocks Fall On Iran Fears, Trump Tariff Ruling Ahead? AI Leader Rises Late

Allspring Mid Cap Growth Fund Q4 2025 Performance Insights, Portfolio Drivers & Decisions

Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates

Guardant Health earnings beat by $0.27, revenue topped estimates

Guardant Health earnings up next: Can Shield growth offset losses?